Impact of Sacubitril/Valsartan on Circulating microRNA in Patients with Heart Failure

Sacubitril/Valsartan, used for the treatment of heart failure (HF), is a combination of two drugs, an angiotensin receptor inhibitor, and a neprilysin inhibitor, which activates vasoactive peptides. Even though its beneficial effects on cardiac functions have been demonstrated, the mechanisms underp...

Descripción completa

Detalles Bibliográficos
Autores principales: Brioschi, Maura, D’Alessandra, Yuri, Mapelli, Massimo, Mattavelli, Irene, Salvioni, Elisabetta, Eligini, Sonia, Mallia, Alice, Ricci, Veronica, Gianazza, Erica, Ghilardi, Stefania, Agostoni, Piergiuseppe, Banfi, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136141/
https://www.ncbi.nlm.nih.gov/pubmed/37189655
http://dx.doi.org/10.3390/biomedicines11041037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136141/
https://www.ncbi.nlm.nih.gov/pubmed/37189655
http://dx.doi.org/10.3390/biomedicines11041037

Ejemplares similares